ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Eylea Injection sBLA
americanpharmaceuticalreview
August 20, 2018Regeneron Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Eylea (aflibercept) Injection in patients with wet age-related macular degeneration (wet AMD).
Pharma Sources Insight July 2025
